logo

For the Inventor, By the Inventor

Cesate, Italy

Paolo Lombardi

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 187(Granted Patents)


Location History:

  • Milan, IT (1980 - 1991)
  • Cesate, IT (1992 - 2012)

Company Filing History:

goldMedal10 out of 140 
 
Farmitalia Carlo Erba S.r.l.
 patents
silverMedal8 out of 208 
 
Farmitalia Carlo Erba
 patents
bronzeMedal7 out of 12 
 
A. Menarini Industrie Farmaceutiche Riunite S.r.l.
 patents
4. 3 out of 39 
 
Bristol-myers Squibb
 patents
5. 2 out of 2 
 
Naxospharma S.r.l.
 patents
6. 1 out of 1 
 
A. Menarini Industrie Farmaceutiche Reiunite S.r.l.
 patent
7. 1 out of 6 
 
Malesci Istituto Farmacobiologico S.p.a.
 patents
8. 1 out of 2 
 
Bristol-meyers Squibb
 patents
9. 1 out of 1 
 
A. Menarini Industrie Farmaceutice Reunite S.r.l.
 patent
10. 1 out of 1 
 
Farmitalia Carlo Ebra S.r.l.
 patent
11. 1 out of 1 
 
Naxopharma S.r.l.
 patent
where one patent can have more than one assignee

Years Active: 1980-2012

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents
1. 8188109 - Benzoquinolizinium salt derivatives as anticancer agents (2012-05-29),
2. 7901904 - Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds (2011-03-08),
3. 7449547 - Process for the synthesis of distamycin and derivatives thereof using 1-methyl-4-formylamino-2-pyrrolecarbonyl chloride iteratively as an intermediate (2008-11-11),
4. 5849795 - Tachykinins antagonists (1998-12-15),
5. 5814608 - S-fluoro-anthracyclines, processes for their preparation and (1998-09-29),
6. 5807835 - 3'-Deamino-4'-deoxy-4'-amino-8-fluoroanthracyclines (1998-09-15),
7. 5801152 - Antracycline disaccharides, process for their preparation, and (1998-09-01),
8. 5760248 - Tachykinin antagonists (1998-06-02),
9. 5698710 - Tachykinins antagonists (1997-12-16),
10. 5670534 - Distamycin a derivatives as anti-malarial agents (1997-09-23),
11. 5641802 - Tachyquinine antagonists, their preparation and use in pharmaceutical (1997-06-24),
12. 5472976 - Poly 4-aminopyrrole-2-carboxyamide derivatives, and pharmaceutical (1995-12-05),
13. 5130472 - Total synthesis of erbstatin analogs (1992-07-14),
14. 4990635 - Synthesis of 6-methylene derivatives of androsta-1,4-diene-3,17-dione (1991-02-05),
15. 4904650 - Substituted androsta-1,4-diene-3,17-diones (1990-02-27),

Title: Paolo Lombardi: Innovator in Anticancer Research

Introduction

Paolo Lombardi, based in Cesate, Italy, is a prominent inventor known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 31 patents, Lombardi has focused his research on developing innovative compounds aimed at treating cancer and other health-related issues. His groundbreaking work exemplifies the intersection of science and patent innovation.

Latest Patents

Among his latest patents, Lombardi has developed "Benzoquinolizinium salt derivatives as anticancer agents." This patent details 13-substituted 5,6-dihydrodibenzo[a,g]quinolizinium salt compounds, outlining processes for their preparation, the pharmaceutical compositions containing these compounds, and their application in manufacturing medicaments suited for treating cancerous diseases. Furthermore, he holds a patent for a "Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds," which involves a method for creating these compounds and the intermediate compounds vital for producing certain physiologically active substances.

Career Highlights

Throughout his career, Paolo Lombardi has worked with notable companies in the pharmaceutical sector, including Farmitalia Carlo Erba S.r.l. and A. Menarini Industrie Farmaceutiche Riunite S.r.l. His experience in these esteemed institutions has been instrumental in advancing his research and patent achievements.

Collaborations

Lombardi has collaborated with several esteemed professionals in his field. Notable coworkers include Enrico Di Salle and Federico Maria Arcamone, who have contributed to his innovative research and development efforts, enhancing the scope and impact of his work.

Conclusion

Paolo Lombardi's contributions to medicinal chemistry, particularly in anticancer research, highlight the vital role of innovation and invention in healthcare. His extensive patent portfolio not only reflects his dedication to scientific advancement but also underscores the importance of collaboration within the research community. Lombardi's work continues to pave the way for new therapeutic options in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…